These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7746313)

  • 1. HIV results in the frame. CD4+ cell turnover.
    Sprent J; Tough D
    Nature; 1995 May; 375(6528):194; author reply 198. PubMed ID: 7746313
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV results in the frame. CD4+ cell turnover.
    Dimitrov DS; Martin MA
    Nature; 1995 May; 375(6528):194-5; author reply 198. PubMed ID: 7746314
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
    Ho DD; Neumann AU; Perelson AS; Chen W; Leonard JM; Markowitz M
    Nature; 1995 Jan; 373(6510):123-6. PubMed ID: 7816094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV results in the frame. Antiviral therapy.
    Phillips AN; Sabin CA; Mocroft A; Janossy G
    Nature; 1995 May; 375(6528):195; author reply 198. PubMed ID: 7746315
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV results in the frame. CD4+ cell turnover.
    Mosier DE
    Nature; 1995 May; 375(6528):193-4; author reply 198. PubMed ID: 7746312
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV results in the frame. Paradox remains.
    Lai S; Page JB; Lai H
    Nature; 1995 May; 375(6528):196-7; author reply 198. PubMed ID: 7746318
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV results in the frame. Other approaches.
    Bukrinsky M; Manogue K; Cerami A
    Nature; 1995 May; 375(6528):195-6; author reply 198. PubMed ID: 7746316
    [No Abstract]   [Full Text] [Related]  

  • 8. [New biological monitoring of HIV infection].
    Morand-Joubert L
    Rev Prat; 1998 Mar; 48(5):472-7. PubMed ID: 9781107
    [No Abstract]   [Full Text] [Related]  

  • 9. High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.
    McNeil AC; Shupert WL; Iyasere CA; Hallahan CW; Mican JA; Davey RT; Connors M
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13878-83. PubMed ID: 11717444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
    Theze J
    Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-specific CD4+ T cells and viremia: who's in control?
    Jansen CA; van Baarle D; Miedema F
    Trends Immunol; 2006 Mar; 27(3):119-24. PubMed ID: 16458605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?
    Grossman Z; Meier-Schellersheim M; Sousa AE; Victorino RM; Paul WE
    Nat Med; 2002 Apr; 8(4):319-23. PubMed ID: 11927927
    [No Abstract]   [Full Text] [Related]  

  • 13. CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation.
    Benito JM; Lopez M; Lozano S; Ballesteros C; Capa L; Martinez P; Gonzalez-Lahoz J; Soriano V
    J Infect Dis; 2005 Dec; 192(12):2142-6. PubMed ID: 16288380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High turnover of HIV in blood revealed by new studies.
    Cohen J
    Science; 1995 Jan; 267(5195):179. PubMed ID: 7809623
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T cell receptor repertoire perturbations in HIV-1 infection: association with plasma viremia and disease progression.
    Malhotra U; Huntsberry C; Holte S; Lee J; Corey L; McElrath MJ
    Clin Immunol; 2006 Apr; 119(1):95-102. PubMed ID: 16403675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor.
    Grant P; Taylor J; Cain P; Short W; Gallant J; Farthing C; Thal G; Coakley E; Zolopa A
    Clin Infect Dis; 2009 Mar; 48(5):680-2. PubMed ID: 19191657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term immunological benefit in patients with discordant responses to therapy depends on both level of viremia and duration of rebound.
    Tomasoni L; Patroni A; Uccelli MC; Gargiulo F; Torti C; Carosi G; Castelli F
    J Infect Dis; 2002 Aug; 186(3):445-6. PubMed ID: 12134248
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure.
    Correa R; Harari A; Vallelian F; Resino S; Munoz-Fernandez MA; Pantaleo G
    AIDS; 2007 Jan; 21(1):23-30. PubMed ID: 17148964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.